Literature DB >> 18728195

Semaphorin 6D regulates the late phase of CD4+ T cell primary immune responses.

Brian P O'Connor1, So-Young Eun, Zhengmao Ye, Alla L Zozulya, John D Lich, Chris B Moore, Heather A Iocca, Kelly E Roney, Eda K Holl, Quing Ping Wu, Hendrick W van Deventer, Zsuzsanna Fabry, Jenny P-Y Ting.   

Abstract

The semaphorin and plexin family of ligand and receptor proteins provides important axon guidance cues required for development. Recent studies have expanded the role of semaphorins and plexins in the regulation of cardiac, circulatory and immune system function. Within the immune system, semaphorins and plexins regulate cell-cell interactions through a complex network of receptor and ligand pairs. Immune cells at different stages of development often express multiple semaphorins and plexins, leading to multivariate interactions, involving more than one ligand and receptor within each functional group. Because of this complexity, the significance of semaphorin and plexin regulation on individual immune cell types has yet to be fully appreciated. In this work, we examined the regulation of T cells by semaphorin 6D. Both in vitro and in vivo T cell stimulation enhanced semaphorin 6D expression. However, semaphorin 6D was only expressed by a majority of T cells during the late phases of activation. Consequently, the targeted disruption of semaphorin 6D receptor-ligand interactions inhibited T cell proliferation at late but not early phases of activation. This proliferation defect was associated with reduced linker of activated T cells protein phosphorylation, which may reflect semaphorin 6D regulation of c-Abl kinase activity. Semaphorin 6D disruption also inhibited expression of CD127, which is required during the multiphase antigen-presenting cell and T cell interactions leading to selection of long-lived lymphocytes. This work reveals a role for semaphorin 6D as a regulator of the late phase of primary immune responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18728195      PMCID: PMC2529027          DOI: 10.1073/pnas.0803386105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling.

Authors:  Toshihiko Toyofuku; Hong Zhang; Atsushi Kumanogoh; Noriko Takegahara; Masanori Yabuki; Koichiro Harada; Masatsugu Hori; Hitoshi Kikutani
Journal:  Nat Cell Biol       Date:  2004-11-14       Impact factor: 28.824

2.  Characterization of the murine immunological signaling network with phosphospecific flow cytometry.

Authors:  Peter O Krutzik; Matthew B Hale; Garry P Nolan
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

3.  Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization.

Authors:  Yves Lepelletier; Ivan Cruz Moura; Réda Hadj-Slimane; Amédée Renand; Susana Fiorentino; Cédric Baude; Anat Shirvan; Ari Barzilai; Olivier Hermine
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

4.  ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.

Authors:  A Hutloff; A M Dittrich; K C Beier; B Eljaschewitsch; R Kraft; I Anagnostopoulos; R A Kroczek
Journal:  Nature       Date:  1999-01-21       Impact factor: 49.962

Review 5.  The B7/CD28 costimulatory family in autoimmunity.

Authors:  Mary E Keir; Arlene H Sharpe
Journal:  Immunol Rev       Date:  2005-04       Impact factor: 12.988

Review 6.  TNF/TNFR family members in costimulation of T cell responses.

Authors:  Tania H Watts
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 7.  Control of CD4+ T-cell memory by cytokines and costimulators.

Authors:  Hans Dooms; Abul K Abbas
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

8.  Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis.

Authors:  Noriko Takegahara; Hyota Takamatsu; Toshihiko Toyofuku; Tohru Tsujimura; Tatsusada Okuno; Kazunori Yukawa; Masayuki Mizui; Midori Yamamoto; Durbaka V R Prasad; Kazuhiro Suzuki; Masaru Ishii; Kenta Terai; Masayuki Moriya; Yuji Nakatsuji; Saburo Sakoda; Shintaro Sato; Shizuo Akira; Kiyoshi Takeda; Masanori Inui; Toshiyuki Takai; Masahito Ikawa; Masaru Okabe; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nat Cell Biol       Date:  2006-05-21       Impact factor: 28.824

9.  CD4 T cells integrate signals delivered during successive DC encounters in vivo.

Authors:  Susanna Celli; Zacarias Garcia; Philippe Bousso
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

10.  Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition.

Authors:  Milka Sarris; Kristian G Andersen; Felix Randow; Luzia Mayr; Alexander G Betz
Journal:  Immunity       Date:  2008-03-06       Impact factor: 31.745

View more
  32 in total

1.  The Impact of TCR Signal Strength on Resident Memory T Cell Formation during Influenza Virus Infection.

Authors:  Jessica K Fiege; Ian A Stone; Elizabeth J Fay; Matthew W Markman; Sathi Wijeyesinghe; Marissa G Macchietto; Steven Shen; David Masopust; Ryan A Langlois
Journal:  J Immunol       Date:  2019-06-24       Impact factor: 5.422

Review 2.  The evolving role of semaphorins and plexins in the immune system: Plexin-A1 regulation of dendritic cell function.

Authors:  Brian P O'Connor; Jenny P-Y Ting
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 3.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

4.  Recipient mucosal-associated invariant T cells control GVHD within the colon.

Authors:  Antiopi Varelias; Mark D Bunting; Kate L Ormerod; Motoko Koyama; Stuart D Olver; Jasmin Straube; Rachel D Kuns; Renee J Robb; Andrea S Henden; Leanne Cooper; Nancy Lachner; Kate H Gartlan; Olivier Lantz; Lars Kjer-Nielsen; Jeffrey Yw Mak; David P Fairlie; Andrew D Clouston; James McCluskey; Jamie Rossjohn; Steven W Lane; Philip Hugenholtz; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 5.  Semaphorins and plexins as therapeutic targets.

Authors:  Thomas Worzfeld; Stefan Offermanns
Journal:  Nat Rev Drug Discov       Date:  2014-08       Impact factor: 84.694

Review 6.  Neuroimmune semaphorins as costimulatory molecules and beyond.

Authors:  Svetlana P Chapoval
Journal:  Mol Med       Date:  2018-04-04       Impact factor: 6.354

7.  Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis.

Authors:  Yanjie Lu; Qian Xu; Lei Chen; Yanzhen Zuo; Shaochen Liu; Yatao Hu; Xiaoru Li; Yuhong Li; Xiangyang Zhao
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

8.  Alteration of payload in extracellular vesicles by crosstalk with mesenchymal stem cells from different origin.

Authors:  Dong Jun Park; Jeong-Eun Park; Tae Hoon Kong; Young Joon Seo
Journal:  J Nanobiotechnology       Date:  2021-05-20       Impact factor: 10.435

Review 9.  The role of semaphorins in immune responses and autoimmune rheumatic diseases.

Authors:  Masayuki Nishide; Atsushi Kumanogoh
Journal:  Nat Rev Rheumatol       Date:  2017-12-07       Impact factor: 20.543

10.  Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classification.

Authors:  Francesco Sambo; Alberto Malovini; Niina Sandholm; Monica Stavarachi; Carol Forsblom; Ville-Petteri Mäkinen; Valma Harjutsalo; Raija Lithovius; Daniel Gordin; Maija Parkkonen; Markku Saraheimo; Lena M Thorn; Nina Tolonen; Johan Wadén; Bing He; Anne-May Osterholm; Jaako Tuomilehto; Maria Lajer; Rany M Salem; Amy Jayne McKnight; Lise Tarnow; Nicolae M Panduru; Nicola Barbarini; Barbara Di Camillo; Gianna M Toffolo; Karl Tryggvason; Riccardo Bellazzi; Claudio Cobelli; Per-Henrik Groop
Journal:  Diabetologia       Date:  2014-05-29       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.